×
Customize
?
Start
Cancer Types
Quick Links
Events
Award Programs
Cure Media Group, LLC.
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 800-210-2873
Copyright © 2019
CURE Media Group.
All rights reserved.
Cure Media Group, LLC. All Rights Reserved.
CURE does not provide medical, diagnostic, or treatment advice.
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 800-210-2873
Copyright © 2019
CURE Media Group.
All rights reserved.
Cure Media Group, LLC. All Rights Reserved.
CURE does not provide medical, diagnostic, or treatment advice.
Immunotherapy
Katie Kosko
Researchers from China examined the impact that coronavirus has on patients who are receiving anti-cancer treatment.
Katie Kosko
Combining immunotherapies with chemotherapy has shown improved survival in patients with extensive-stage small cell lung cancer.
Sonya Collins
Patients with relapsed and resistant diffuse large B-cell lymphoma can look to new treatments beyond tried-and-true chemotherapy.
Ryan McDonald
The combination of Keytruda plus chemoradiotherapy induced a ‘promising’ 12-month progression-free survival rate in patients with locally advanced non-small cell lung cancer.
Katie Kosko
Treatment for patients with bladder cancer is moving away from VEGF-targeted therapies toward immune checkpoint inhibition, according to one expert.
Kristie L. Kahl and Lee Greenberger
Lee Greenberger, chief scientific officer at the Leukemia and Lymphoma Society, discusses the use of immunotherapy in blood cancer treatment.
Perspectives on treatment decision-making in cutaneous squamous cell carcinoma, particularly regarding who is involved in selecting therapy.
Dr. Todd Schlesinger shares his experience with cemiplimab, an immunotherapy agent used to treat cutaneous squamous cell carcinoma.
Considerations for the use of immunotherapy, a novel approach to treatment, in patients with cutaneous squamous cell carcinoma.
V Foundation
Top Translational Grants Named for Former CEO Nick Valvano, Former Scientific Advisory Committee Chair Dr. Robert Bast.